CLINICAL_TRIALS
trial_result
· 2020-07-23
Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
Summary
Phase 2 clinical trial update on hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy has completed with results posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Status: COMPLETED | Results posted: 2020-07-23